Green Cross Holdings Corporation (005257.KS)
KRW 23150.0
(1.09%)
KRW 23150.0
(1.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 424.43 Billion KRW | -15.2% |
| 2022 | 500.54 Billion KRW | 12.01% |
| 2021 | 446.85 Billion KRW | 14.48% |
| 2020 | 390.34 Billion KRW | 17.57% |
| 2019 | 332.02 Billion KRW | 12.31% |
| 2018 | 295.62 Billion KRW | 6.91% |
| 2017 | 276.5 Billion KRW | 1.05% |
| 2016 | 273.62 Billion KRW | 10.64% |
| 2015 | 247.31 Billion KRW | 15.82% |
| 2014 | 213.53 Billion KRW | 8.9% |
| 2013 | 196.08 Billion KRW | 9.41% |
| 2012 | 179.22 Billion KRW | 4.94% |
| 2011 | 170.78 Billion KRW | 1.02% |
| 2010 | 169.06 Billion KRW | 12.44% |
| 2009 | 150.35 Billion KRW | 10.31% |
| 2008 | 136.31 Billion KRW | 11.77% |
| 2007 | 121.95 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 399.8 Billion KRW | 320.37% |
| 2024 Q1 | 95.1 Billion KRW | -9.84% |
| 2024 Q3 | 425.3 Billion KRW | -73.51% |
| 2023 FY | 424.43 Billion KRW | -15.2% |
| 2023 Q4 | 105.49 Billion KRW | 197.59% |
| 2023 Q3 | -108.09 Billion KRW | -1822.68% |
| 2023 Q2 | 6.27 Billion KRW | -94.45% |
| 2023 Q1 | 113.05 Billion KRW | -23.5% |
| 2022 Q4 | 147.77 Billion KRW | 22.7% |
| 2022 Q1 | 103.52 Billion KRW | -25.91% |
| 2022 Q2 | 128.79 Billion KRW | 24.4% |
| 2022 FY | 500.54 Billion KRW | 12.01% |
| 2022 Q3 | 120.43 Billion KRW | -6.49% |
| 2021 Q3 | 113.92 Billion KRW | 7.81% |
| 2021 Q4 | 139.74 Billion KRW | 22.66% |
| 2021 Q1 | 87.51 Billion KRW | -31.25% |
| 2021 FY | 446.85 Billion KRW | 14.48% |
| 2021 Q2 | 105.67 Billion KRW | 20.76% |
| 2020 Q3 | 92.1 Billion KRW | 4.19% |
| 2020 Q1 | 82.55 Billion KRW | -17.8% |
| 2020 Q4 | 127.28 Billion KRW | 38.21% |
| 2020 FY | 390.34 Billion KRW | 17.57% |
| 2020 Q2 | 88.39 Billion KRW | 7.08% |
| 2019 FY | 332.02 Billion KRW | 12.31% |
| 2019 Q4 | 100.42 Billion KRW | 24.23% |
| 2019 Q2 | 78.92 Billion KRW | 9.88% |
| 2019 Q3 | 80.84 Billion KRW | 2.43% |
| 2019 Q1 | 71.82 Billion KRW | -9.51% |
| 2018 Q3 | 75.02 Billion KRW | 0.95% |
| 2018 FY | 295.62 Billion KRW | 6.91% |
| 2018 Q4 | 79.37 Billion KRW | 5.79% |
| 2018 Q2 | 74.32 Billion KRW | 11.1% |
| 2018 Q1 | 66.89 Billion KRW | -15.8% |
| 2017 FY | 276.5 Billion KRW | 1.05% |
| 2017 Q4 | 79.45 Billion KRW | 12.47% |
| 2017 Q3 | 70.64 Billion KRW | 6.65% |
| 2017 Q2 | 66.23 Billion KRW | 10.08% |
| 2017 Q1 | 60.17 Billion KRW | -22.07% |
| 2016 FY | 273.62 Billion KRW | 10.64% |
| 2016 Q3 | 69.23 Billion KRW | 0.52% |
| 2016 Q4 | 77.21 Billion KRW | 11.53% |
| 2016 Q2 | 68.87 Billion KRW | 18.16% |
| 2016 Q1 | 58.29 Billion KRW | -25.44% |
| 2015 FY | 247.31 Billion KRW | 15.82% |
| 2015 Q4 | 78.18 Billion KRW | 36.34% |
| 2015 Q1 | 52.52 Billion KRW | -15.69% |
| 2015 Q3 | 57.34 Billion KRW | -3.24% |
| 2015 Q2 | 59.26 Billion KRW | 12.82% |
| 2014 Q4 | 62.3 Billion KRW | 22.75% |
| 2014 Q3 | 50.75 Billion KRW | 1.32% |
| 2014 Q1 | 50.38 Billion KRW | -9.01% |
| 2014 Q2 | 50.09 Billion KRW | -0.59% |
| 2014 FY | 213.53 Billion KRW | 8.9% |
| 2013 Q3 | 49.92 Billion KRW | 8.76% |
| 2013 Q1 | 44.87 Billion KRW | -25.22% |
| 2013 Q4 | 55.37 Billion KRW | 10.91% |
| 2013 FY | 196.08 Billion KRW | 9.41% |
| 2013 Q2 | 45.9 Billion KRW | 2.3% |
| 2012 Q1 | 35.97 Billion KRW | -29.49% |
| 2012 Q4 | 60 Billion KRW | 43.11% |
| 2012 Q3 | 41.92 Billion KRW | 1.47% |
| 2012 Q2 | 41.32 Billion KRW | 14.88% |
| 2012 FY | 179.22 Billion KRW | 4.94% |
| 2011 Q4 | 51.01 Billion KRW | 23.61% |
| 2011 FY | 170.78 Billion KRW | 1.02% |
| 2011 Q3 | 41.26 Billion KRW | -2.33% |
| 2011 Q2 | 42.25 Billion KRW | 16.82% |
| 2011 Q1 | 36.17 Billion KRW | 0.0% |
| 2010 Q1 | 43.53 Billion KRW | -11.11% |
| 2010 Q3 | 43.45 Billion KRW | 23.0% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 FY | 169.06 Billion KRW | 12.44% |
| 2010 Q2 | 35.32 Billion KRW | -18.86% |
| 2009 Q2 | 33.38 Billion KRW | 5.55% |
| 2009 Q1 | 31.63 Billion KRW | -14.04% |
| 2009 Q3 | 36.64 Billion KRW | 9.77% |
| 2009 Q4 | 48.97 Billion KRW | 33.65% |
| 2009 FY | 150.35 Billion KRW | 10.31% |
| 2008 Q4 | 36.79 Billion KRW | 8.73% |
| 2008 FY | 136.31 Billion KRW | 11.77% |
| 2008 Q3 | 33.84 Billion KRW | 6.28% |
| 2008 Q2 | 31.84 Billion KRW | -6.68% |
| 2008 Q1 | 34.12 Billion KRW | 1.02% |
| 2007 Q1 | 27.71 Billion KRW | 0.0% |
| 2007 Q3 | 31.89 Billion KRW | 11.68% |
| 2007 Q4 | 33.77 Billion KRW | 5.89% |
| 2007 FY | 121.95 Billion KRW | 0.0% |
| 2007 Q2 | 28.56 Billion KRW | 3.06% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ORIENT BIO Inc. | 10.23 Billion KRW | -4048.77% |
| Green Cross Holdings Corporation | 620.02 Billion KRW | 31.545% |
| Pharmicell Co., Ltd. | 14 Billion KRW | -2930.761% |
| Green Cross Corporation | 424.43 Billion KRW | 0.0% |
| GeneOne Life Science, Inc. | 40.6 Billion KRW | -945.177% |
| Celltrion, Inc. | 359.46 Billion KRW | -18.072% |
| Samsung Biologics Co.,Ltd. | 638.51 Billion KRW | 33.528% |
| SK bioscience Co.,Ltd. | 154.23 Billion KRW | -175.194% |
| SK Biopharmaceuticals Co., Ltd. | 358.33 Billion KRW | -18.447% |
| Prestige BioPharma Limited | 63.47 Billion KRW | -568.694% |